H2BC21 and neoplasm: While decreased H2Bub1 levels have been linked to tumor progression and poor survival in several cancer entities, including CRC [16], we report for the first time that H2B monoubiquitination is reduced in inflamed areas in 80% of Crohn’s disease patients.